Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP91226.RABUCZzO7vCxMFLLJ-QdOD2EjEfJtKK8f1aeeX0p7EkpE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP91226.RABUCZzO7vCxMFLLJ-QdOD2EjEfJtKK8f1aeeX0p7EkpE130_assertion type Assertion NP91226.RABUCZzO7vCxMFLLJ-QdOD2EjEfJtKK8f1aeeX0p7EkpE130_head.
- NP91226.RABUCZzO7vCxMFLLJ-QdOD2EjEfJtKK8f1aeeX0p7EkpE130_assertion description "[Polymorphic variations in the MTR, SLC19A1, and TYMS genes were associated with better clinical response to combination DMARD regimens containing MTX and SSZ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91226.RABUCZzO7vCxMFLLJ-QdOD2EjEfJtKK8f1aeeX0p7EkpE130_provenance.
- NP91226.RABUCZzO7vCxMFLLJ-QdOD2EjEfJtKK8f1aeeX0p7EkpE130_assertion evidence source_evidence_literature NP91226.RABUCZzO7vCxMFLLJ-QdOD2EjEfJtKK8f1aeeX0p7EkpE130_provenance.
- NP91226.RABUCZzO7vCxMFLLJ-QdOD2EjEfJtKK8f1aeeX0p7EkpE130_assertion SIO_000772 18322994 NP91226.RABUCZzO7vCxMFLLJ-QdOD2EjEfJtKK8f1aeeX0p7EkpE130_provenance.
- NP91226.RABUCZzO7vCxMFLLJ-QdOD2EjEfJtKK8f1aeeX0p7EkpE130_assertion wasDerivedFrom gad-20150221 NP91226.RABUCZzO7vCxMFLLJ-QdOD2EjEfJtKK8f1aeeX0p7EkpE130_provenance.
- NP91226.RABUCZzO7vCxMFLLJ-QdOD2EjEfJtKK8f1aeeX0p7EkpE130_assertion wasGeneratedBy ECO_0000203 NP91226.RABUCZzO7vCxMFLLJ-QdOD2EjEfJtKK8f1aeeX0p7EkpE130_provenance.